Upper Respiratory Infection Clinical Trial
Official title:
Improving Communication During Pediatric Visits for Acute Respiratory Illness
Verified date | July 2010 |
Source | University of Washington |
Contact | n/a |
Is FDA regulated | No |
Health authority | United States: Institutional Review Board |
Study type | Interventional |
The excessive use of outpatient antibiotics in the pediatric population has contributed to
the rapid development of resistance in many strains of Streptococcus pneumoniae. Research
has shown that community-based interventions may have a modest impact on reducing the
injudicious use of antibiotics in children. However, since the actual prescribing of
antibiotics is done by physicians and research has shown that physician-parent communication
patterns during pediatric visits for acute respiratory tract infections (ARTI) strongly
influence antibiotic prescription rate, it is crucial to develop effective interventions
aimed specifically at them.
The overall goal of this study is to improve physician-parent communication patterns during
visits for pediatric ARTI and, ultimately, to decrease rates of antibiotic prescribing for
these illnesses in children.
Status | Completed |
Enrollment | 1313 |
Est. completion date | April 2009 |
Est. primary completion date | April 2009 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 19 Years and older |
Eligibility |
Inclusion Criteria: - Parents: the parent must present with a child between the ages of 6 months and 10 years old, who has not received antibiotics for any reason in the prior two weeks and who has any of the following symptoms: cough, runny nose/congestion, sore throat, ear pain, or ear tugging. Parents must be able to read English or Spanish; the visit must occur during one of the three data collection periods for the participating physician; and parents must have not previously participated in teh study. - Physicians: physician must be a member of Puget Sound Pediatric research Network (PSPRN). Exclusion Criteria: - Parents: parents who are 18 years of age or less - Physicians: physicians who are not members of PSPRN |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of Washington |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effectiveness of intervention in changing physician communication behaviors | To evaluate the effectiveness of the proposed intervention in achieving its stated goals of changing physician communication behavoirs | 12 months | No |
Secondary | Antibiotic prescribing rates as a function of the intervention | To determine the antibiotic prescribing rates for children aged 6 months to 10 years presenting with ARTI symptoms and assess how these rates change as a function of the intervention | 12 months | No |
Secondary | Satisfaction levels for parents as a function of the intervention | To determine visit-specific satisfaction levels for parents of children seen by study physicians and assess how satisfaction levels change as a function of the intervention | 12 months | No |
Secondary | Factor identification | To identify the factors (e.g., physician communication behaviors) that mediate the relationships between physicians being in the intervention group, decreased antibiotic prescribing, and increased parent satisfaction with care | 12 months | No |
Secondary | Validation study of the PCBI | To perform a validation study of the Physician Communication Behavior Inventory (PCBI) survey items. Using a standardized approach, specific physician communication behaviors will be coded through review of 100 video taped physician-parent encounters. The behaviors coded will be compared to parent responses on the PCBI surveys from these encounters. | 12 months | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03711292 -
Using Behavioral Science to Reduce Inappropriate Antibiotic Use in Acute Care Settings
|
N/A | |
Terminated |
NCT00187785 -
Doctor-Patient Communication in Spanish
|
N/A | |
Completed |
NCT00405509 -
The Natural History of Viral Upper Respiratory Infections in Children Aged 6 to Less Than 14 Years
|
N/A | |
Completed |
NCT00189475 -
Evaluate the Potential of Montelukast to Prevent Nasal Symptomatology During Colds
|
Phase 4 | |
Completed |
NCT04468204 -
Use of Novel Sinusonic Device for Prevention of Community Acquired Upper Respiratory Infection (URI)
|
N/A | |
Active, not recruiting |
NCT05666752 -
Effect of Intake of Allium Cepa L. Peel Heated Water Extract on Immunity Enhancement
|
N/A | |
Completed |
NCT00255307 -
Pilot Evaluation of CVT-E002 in Pediatric Upper Respiratory Tract Infection.
|
Phase 2 | |
Suspended |
NCT05035420 -
A Noninvasive Multimodal Biosensing Device for Screening and Monitoring Response to Treatment of Infectious Respiratory Diseases
|
N/A | |
Recruiting |
NCT06244615 -
Clinical Trial of a Mouth and Throat Rinse for the Treatment of Acute Sore Throat
|
N/A | |
Completed |
NCT02694679 -
Randomized Controlled Trial of Social Network Targeting in Honduras
|
N/A | |
Completed |
NCT05352581 -
BD Veritorâ„¢ At-Home and BD Veritorâ„¢ Professional
|
||
Active, not recruiting |
NCT02943551 -
Dialogue Around Respiratory Illness Treatment
|
N/A | |
Completed |
NCT01657643 -
Effect of Probiotics on Health-related Quality of Life in College Students With Upper Respiratory Infections
|
N/A | |
Completed |
NCT02110732 -
Lactobacillus Rhamnosus GG in the Middle Ear and Adenoid Tonsil
|
N/A | |
Completed |
NCT00694421 -
Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 2
|
N/A | |
Completed |
NCT03884777 -
Incidence and Risk of Influenza in Myasthenic Patients
|
||
Completed |
NCT00796315 -
Study Evaluating the Pharmacokinetics of Doxylamine Succinate in Children
|
Phase 1 | |
Completed |
NCT00642681 -
Effects of URI on Diabetic Subjects Utilizing Technosphere Insulin After a Meal Challenge
|
Phase 2 | |
Completed |
NCT00259831 -
Efficacy of Cold-FX (CVT-E002) in the Prevention of Upper Respiratory Tract Infections in Healthy Adults
|
Phase 3 | |
Completed |
NCT04588376 -
Improving Antibiotic Prescribing for Pediatric Respiratory Infections by Family Physicians With Peer Comparison
|
N/A |